Welcome to LookChem.com Sign In|Join Free

CAS

  • or

10030-93-0

Post Buying Request

10030-93-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

10030-93-0 Usage

Description

TRI-ACETYL PYRIDOXINE, a derivative of vitamin B6, is a water-soluble vitamin that is essential for various physiological functions, including protein synthesis, metabolism, and nervous system development. TRI-ACETYL PYRIDOXINE has been acetylated three times, enhancing its stability and bioavailability compared to its natural form. TRI-ACETYL PYRIDOXINE is widely recognized for its potential health benefits and applications in the medical field, particularly in addressing vitamin B6 deficiency and exploring therapeutic benefits for conditions such as epilepsy, diabetes, and cardiovascular disease.

Uses

Used in Pharmaceutical Industry:
TRI-ACETYL PYRIDOXINE is used as a supplement for treating vitamin B6 deficiency, ensuring the body has adequate levels of this essential nutrient to support various physiological processes.
Used in Neurological Applications:
TRI-ACETYL PYRIDOXINE is used as a therapeutic agent for epilepsy, where it has shown potential in reducing the frequency and severity of seizures by modulating neurotransmitter synthesis and function.
Used in Endocrine Applications:
In the treatment of diabetes, TRI-ACETYL PYRIDOXINE is used to support insulin production and glucose metabolism, helping to manage blood sugar levels and reduce the risk of complications associated with diabetes.
Used in Cardiovascular Applications:
TRI-ACETYL PYRIDOXINE is used to support cardiovascular health by potentially reducing the risk of heart disease through its involvement in lipid metabolism and the maintenance of healthy blood vessels.
Overall, TRI-ACETYL PYRIDOXINE is a versatile compound with significant applications across various medical and health-related fields, offering promising benefits for the prevention and treatment of a range of conditions.

Check Digit Verification of cas no

The CAS Registry Mumber 10030-93-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,0,0,3 and 0 respectively; the second part has 2 digits, 9 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 10030-93:
(7*1)+(6*0)+(5*0)+(4*3)+(3*0)+(2*9)+(1*3)=40
40 % 10 = 0
So 10030-93-0 is a valid CAS Registry Number.

10030-93-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 10, 2017

Revision Date: Aug 10, 2017

1.Identification

1.1 GHS Product identifier

Product name [5-acetyloxy-4-(acetyloxymethyl)-6-methylpyridin-3-yl]methyl acetate

1.2 Other means of identification

Product number -
Other names essigsaeure-<4,5-bis(acetoxymethyl)-2-methylpyridin-3-yl>ester

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:10030-93-0 SDS

10030-93-0Relevant articles and documents

Vitamin B6; A new synthesis by Diels-Alder reaction

Boell,Koenig

, p. 1657 - 1664 (1979)

-

-

Harris et al.

, p. 3198,3202 (1940)

-

MULTIBIOTIC AGENTS AND METHODS OF USING THE SAME

-

Page/Page column 118, (2019/01/06)

Multibiotic agents are disclosed. The multibiotic agents may contain two or more moieties linked through bonds cleavable in vivo. The bonds cleavable in vivo can be ester bonds, amide bonds, azo bonds, glycosidic bonds, carbonate linkers, or carbamate linkers. The moieties can be alcohol cores, amine cores, and/or acyls. Also disclosed are compositions containing multibiotic agents and methods of using the multibiotic agents.

1,3 DIHYDROFURO [3,4-c]PYRIDINES AND THEIR PREPARATION

-

Page/Page column 8, (2010/02/14)

The present invention relates to novel 1,3-dihydrofuro[3,4-c]pyridines which are useful intermediates in the synthesis of pyridoxines and a method for their preparation by cobalt(I) complex-catalysed [2 + 2 + 2]-cycloaddition of di-[(3-dimethyl-C1-4-alkoxysilyl)-2-propynyl)] ethers with acetonitrile.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 10030-93-0